When is nebulized epinephrine indicated in pediatric respiratory illness treated by EMS?

Prepare for the Pediatric Education for Prehospital Professionals (PEPP) Exam. Use flashcards and multiple-choice questions with clear explanations to ace your exam!

Multiple Choice

When is nebulized epinephrine indicated in pediatric respiratory illness treated by EMS?

Explanation:
Nebulized epinephrine is used in pediatric EMS care primarily for croup when there is stridor at rest or notable airway obstruction. The medication works by causing rapid alpha-adrenergic–mediated vasoconstriction in the upper airway mucosa, which reduces subglottic edema and widens the airway, producing quick relief of obstruction while other treatments take effect. This is the situation where the benefit is most clear and the protocol supports its use. It isn’t routinely used for asthma that isn’t controlled with albuterol, bronchiolitis with wheeze, or pneumonia, because those conditions involve different parts of the respiratory system or different pathophysiology, and their standard EMS treatments target bronchodilation, inflammation, infection, or supportive care rather than acute upper-airway edema. Monitor the patient after administration for heart rate, blood pressure changes, and watch for rebound symptoms as the effect wears off.

Nebulized epinephrine is used in pediatric EMS care primarily for croup when there is stridor at rest or notable airway obstruction. The medication works by causing rapid alpha-adrenergic–mediated vasoconstriction in the upper airway mucosa, which reduces subglottic edema and widens the airway, producing quick relief of obstruction while other treatments take effect. This is the situation where the benefit is most clear and the protocol supports its use. It isn’t routinely used for asthma that isn’t controlled with albuterol, bronchiolitis with wheeze, or pneumonia, because those conditions involve different parts of the respiratory system or different pathophysiology, and their standard EMS treatments target bronchodilation, inflammation, infection, or supportive care rather than acute upper-airway edema. Monitor the patient after administration for heart rate, blood pressure changes, and watch for rebound symptoms as the effect wears off.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy